{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:41:41Z","timestamp":1790138501621,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pathol.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:21:07Z","timestamp":1723501267000},"page":"993-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["TIGIT expression on neoplastic cells is a poor prognostic factor for adult T-cell leukaemia\/lymphoma"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5984-7642","authenticated-orcid":false,"given":"Yuichi","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-3725","authenticated-orcid":false,"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2954-5691","authenticated-orcid":false,"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2024.06.003_bib1","series-title":"In: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"281","article-title":"Adult T-cell leukemia\/lymphoma","author":"Ohshima","year":"2008"},{"key":"10.1016\/j.pathol.2024.06.003_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2024.06.003_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.12962","article-title":"Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)","volume":"166","author":"Fukushima","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2024.06.003_bib4","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-14-0572","article-title":"Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research","volume":"20","author":"Tsukasaki","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2024.06.003_bib5","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2024.06.003_bib6","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"ATL-Prognostic Index Project. Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2024.06.003_bib7","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1038\/bcj.2013.57","article-title":"Association between decreasing trend in the mortality of adult T-cell leukemia\/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT)","volume":"3","author":"Chihara","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.pathol.2024.06.003_bib8","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2024.06.003_bib9","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.pathol.2024.06.003_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/ph14030200","article-title":"TIGIT\/CD226 axis regulates anti-tumor immunity","volume":"14","author":"Yeo","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pathol.2024.06.003_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pathol.2024.06.003_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/eji.200839116","article-title":"A\u00a0novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC","volume":"39","author":"Boles","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pathol.2024.06.003_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/eji.201041136","article-title":"Vstm3 is a member of the CD28 family and an important modulator of T-cell function","volume":"41","author":"Levin","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pathol.2024.06.003_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/cei.13407","article-title":"TIGIT as an emerging immune checkpoint","volume":"200","author":"Harjunp\u00e4\u00e4","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pathol.2024.06.003_bib15","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2018-01-825265","article-title":"TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma","volume":"132","author":"Guillerey","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2024.06.003_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT)","volume":"12","author":"Yasuma","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.pathol.2024.06.003_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12977-020-0511-0","article-title":"HTLV-1 bZIP factor: the key viral gene for pathogenesis","volume":"17","author":"Matsuoka","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.pathol.2024.06.003_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2024.06.003_bib19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1158\/2326-6066.CIR-18-0713","article-title":"Function of human tumor-infiltrating lymphocytes in early-stage non-small cell lung cancer","volume":"7","author":"O\u2019Brien","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.pathol.2024.06.003_bib20","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/cam4.2167","article-title":"Expression of immune checkpoint receptors indoleamine 2,3-dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma","volume":"8","author":"St\u00e5lhammar","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.pathol.2024.06.003_bib21","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1158\/1078-0432.CCR-15-2626","article-title":"T-cell immunoglobulin and ITIM domain (TIGIT) associates with CD8+ T-cell exhaustion and poor clinical outcome in AML patients","volume":"22","author":"Kong","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2024.06.003_bib22","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1158\/0008-5472.CAN-17-0381","article-title":"CD155T\/TIGIT signaling regulates CD8 T-cell metabolism and promotes tumor progression in human gastric cancer","volume":"77","author":"He","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2024.06.003_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1593807","article-title":"Clinical significance of CD8+ T cell immunoreceptor with Ig and ITIM domains+ in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomy","volume":"8","author":"Tang","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pathol.2024.06.003_bib24","series-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.pathol.2024.06.003_bib25","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2024.06.003_bib26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00277-020-03967-x","article-title":"Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia\/lymphoma","volume":"99","author":"Takeuchi","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2024.06.003_bib27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2016-02-698936","article-title":"PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma","volume":"128","author":"Miyoshi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2024.06.003_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41379-020-00654-0","article-title":"Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia\/lymphoma","volume":"34","author":"Yamada","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2024.06.003_bib29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/his.13461","article-title":"Expression pattern of immunosurveillance-related antigen in adult T cell leukaemia\/lymphoma","volume":"72","author":"Asano","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2024.06.003_bib30","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3324\/haematol.2018.205567","article-title":"Human leukocyte antigen class II expression is a good prognostic factor of adult T-cell leukemia\/lymphoma","volume":"104","author":"Takeuchi","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2024.06.003_bib31","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1002\/cam4.4200","article-title":"Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma","volume":"10","author":"Arakawa","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.pathol.2024.06.003_bib32","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2024.06.003_bib33","doi-asserted-by":"crossref","first-page":"17858","DOI":"10.1073\/pnas.0903474106","article-title":"The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity","volume":"106","author":"Stanietsky","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2024.06.003_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2024.06.003_bib35","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.1103627","article-title":"The TIGIT\/CD226 axis regulates human T cell function","volume":"188","author":"Lozano","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2024.06.003_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.pathol.2024.06.003_bib37","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2010-12-326199","article-title":"HTLV-1 bZIP factor enhances TGF-\u03b2 signaling through p300 coactivator","volume":"118","author":"Zhao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2024.06.003_bib38","article-title":"HTLV-1 bZIP factor enhances T-cell proliferation by impeding the suppressive signaling of co-inhibitory receptors","volume":"13","author":"Kinosada","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.pathol.2024.06.003_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/366076a0","article-title":"B70 antigen is a second ligand for CTLA-4 and CD28","volume":"366","author":"Azuma","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2024.06.003_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1126\/science.7694363","article-title":"Cloning of B 7\u20132: a CTLA-4 counter \u2013 receptor that costimulates human T cell proliferation","volume":"262","author":"Freeman","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.pathol.2024.06.003_bib41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/978-0-387-89520-8_11","article-title":"GITR: a modulator of immune response and inflammation","volume":"647","author":"Nocentini","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pathol.2024.06.003_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13073-023-01259-3","article-title":"GITR and TIGIT immunotherapy provokes divergent multi-cellular responses in the tumor microenvironment of gastrointestinal cancers","volume":"15","author":"Anuja","year":"2023","journal-title":"Genome Med"},{"key":"10.1016\/j.pathol.2024.06.003_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1838141","article-title":"Tumor-infiltrating TNFRSF9+ CD8+ T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response","volume":"9","author":"Li","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pathol.2024.06.003_bib44","series-title":"A\u00a0study of Tiragolumab in combination with atezolizumab compared with placebo in combination with atezolizumab in patients with previously untreated locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (SKYSCRAPER-01)","year":"2024"},{"key":"10.1016\/j.pathol.2024.06.003_bib45","article-title":"KeyVibe-008: randomized, phase 3 study of first-line vibostolimab plus pembrolizumab plus etoposide\/platinum versus atezolizumab plus EP in extensive- stage small cell lung cancer","volume":"40","author":"Stands","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2024.06.003_bib46","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2021-152395","article-title":"TIG-007: study of EOS884448\/GSK4428859A alone, and in combination with iberdomide with or without dexamethasone. In: participants with relapsed or refractory multiple myeloma","volume":"138","author":"Moreau","year":"2021","journal-title":"Blood"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524001879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524001879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:07:02Z","timestamp":1730826422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302524001879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0031302524001879"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2024.06.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIGIT expression on neoplastic cells is a poor prognostic factor for adult T-cell leukaemia\/lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}